BIOVICA INTERNATIONAL AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.75 SEK | +2.04% |
|
+5.77% | +6.59% |
| 06-28 | Biovica to Provide Biomarker Testing for US Biopharmaceutical Company | MT |
| 06-28 | Biovica International Signs New Agreement Supporting Pharma Development | CI |
Evolution of the average Target Price on Biovica International AB
Price target over the last 5 years
History of analyst recommendation changes
0f694ca9dfd38e2a0d514.VGpQ9hz65vsUHf7d-mI5kl6SpdBgN3nKJooq0ROvjkM.Bj81hVaVsMN4R5eciyZ1xiTB3LQTRRL9R7xuvVbw6iAGJmSCRqLWuGN4yg~359f4bf97f186e9681631414be7c277e
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.75
SEK
Average target price
7.9
SEK
Spread / Average Target
+187.27%
High Price Target
11
SEK
Spread / Highest target
+300.00%
Low Price Target
4.8
SEK
Spread / Lowest Target
+74.55%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
D
EPS Revisions
- Stock Market
- Equities
- BIOVIC B Stock
- Consensus Biovica International AB
